Trading Signals: BCRX Stock Price Prediction and Forecast (Tue. Sep. 2, 2003 - Wed. Sep. 27, 2023)(BioCryst Pharmaceuticals, Inc.)
| BCRX latest price $13.3600 (-4.78%) ($13.3600 - $13.3600) on Mon. Oct. 31, 2022. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 3.85% (three month average) | RSI | 46 | Latest Price | $13.3600(-4.78%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | BCRX declines -0.7% a day on average for past five trading days. | Weekly Trend | BCRX declines -0.2% a week on average for past two weeks. | Market Behavior | Growth stock sell-off for large cap. Normal for small cap. | Correlated ETFs | Broad market will support BCRX advance at 0% a week (0% probability) XLK(27%) URA(26%) VUG(26%) VT(25%) BLOK(24%) | Factors Impacting BCRX price | BCRX will decline at least -1.925% in a week (0% probabilities). SMH(-17%) VIXM(-11%) UUP(-6%) ARKG(-3%) VXX(-2%) | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -1.925% (StdDev 3.85%) | Hourly BBV | -1.7 () | Intraday Trend | 0% | | | |
|
Resistance Level | $13.78 | 5 Day Moving Average | $13.7(-2.48%) | 10 Day Moving Average | $13.72(-2.62%) | 20 Day Moving Average | $13.78(-3.05%) | To recent high | -9.9% | To recent low | 23.5% | Market Cap | $2.357b | | | | BioCryst Pharmaceuticals, Inc. designs and develops novel, oral and small-molecule medicines. Its drug candidates include Berotralstat, BCX9930, BCX9250, RAPIVAB, ALPIVAB, RAPIACTA, PERAMIFLU, Galidesivir and Mundesine. The company was founded in 1986 and is headquartered in Durham, NC. |